CINXE.COM
JNNP Podcast | BMJ Group
<!DOCTYPE html> <html data-head-attrs="" lang="en"> <head> <meta charset="UTF-8"> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta name="mobile-web-app-capable" content="yes"> <meta name="apple-mobile-web-app-status-bar-style" content="black"> <meta name="theme-color" content="#ffffff"> <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/5.0.1/css/bootstrap.min.css" integrity="sha512-Ez0cGzNzHR1tYAv56860NLspgUGuQw16GiOOp/I2LuTmpSK9xDXlgJz3XN4cnpXWDmkNBKXR/VDMTCnAaEooxA==" crossorigin="anonymous" referrerpolicy="no-referrer" /> <link rel="preconnect" href="https://fonts.googleapis.com"> <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin> <script type="module" crossorigin src="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/index.5b5f247f.js"></script> <link rel="modulepreload" href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/vendor.926efe0f.js"> <link rel="stylesheet" href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/index.b464827f.css"> <link rel="manifest" href="/user-site/manifest.webmanifest" crossorigin="use-credentials"><title>JNNP Podcast | BMJ Group</title><link rel="icon" href="https://mcdn.podbean.com/mf/web/c3v67p/JNNP.jpg"><link rel="apple-touch-icon" href="https://mcdn.podbean.com/mf/web/c3v67p/JNNP.jpg"><meta name="description" content="The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP鈥檚 ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. Encompassing the entire genre of neurological scie..."><meta property="og:title" content="JNNP Podcast | BMJ Group"><meta property="og:url" content="https://jnnpbmj.podbean.com/"><meta property="og:image" content="https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464412/JNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg"><meta property="og:description" content="The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP鈥檚 ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. Encompassing the entire genre of neurological scie..."><meta property="og:type" content="article"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@podbeancom"><meta name="twitter:url" content="https://jnnpbmj.podbean.com/"><meta name="twitter:title" content="JNNP Podcast | BMJ Group"><meta name="twitter:description" content="The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP鈥檚 ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. Encompassing the entire genre of neurological scie..."><meta name="twitter:image" content="https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16464412/JNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="Content-Language" content="en-us"><meta name="generator" content="Podbean 3.2"><meta name="viewport" content="width=device-width, user-scalable=no, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0"><meta name="author" content="PodBean Development"><meta name="Copyright" content="PodBean"><meta name="HandheldFriendly" content="True"><meta name="MobileOptimized" content="MobileOptimized"><meta name="robots" content="all"><meta name="twitter:app:id:googleplay" content="com.podbean.app.generic"><meta name="twitter:app:id:ipad" content="1484287462"><meta name="twitter:app:id:iphone" content="1484287462"><meta name="twitter:app:name:googleplay" content="Podbean Biz Podcast App"><meta name="twitter:app:name:ipad" content="Podbean Biz Podcast App"><meta name="twitter:app:name:iphone" content="Podbean Biz Podcast App"><script type="application/ld+json">[{"@context":"https://schema.org/","@type":"PodcastSeries","image":"https://pbcdn1.podbean.com/imglogo/image-logo/16464412/JNNP.jpg","url":"https://jnnpbmj.podbean.com","name":"JNNP Podcast","description":"The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP鈥檚 ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. \nEncompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson鈥檚 disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.\n\nJoin Dr. Saima Chaudhry as she hosts in-depth interviews with authors, providing a deeper understanding of their work and shedding new light on their findings. Stay informed with expert discussions and cutting-edge information by subscribing or listening on your favourite podcast platform.","webFeed":"https://feed.podbean.com/jnnpbmj/feed.xml","publisher":{"@type":"Organization","name":"BMJ Podcasts","url":"https://www.podbean.com/podcast-network/BMJPodcasts"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/distinguishing-autoimmune-nodopathies-from-cidp/","name":"Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer","datePublished":"2024-07-15","description":"Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be difficult to distinguish from autoimmune nodopathy. In this podcast, Dr. Saima Chaudhry (1) is joined from the Netherlands by Dr. Ruth Huizinga (2) and Dr. Maarten Titulaer (3), to discuss their article, \"Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort\". They start with explaining what an autoimmune nodopathy really is, patient features to look out for, and the typical testing process for identifying CIDP.(1) Warren Alpert Medical School, Brown University, Rhode Island, USA(2) Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands(3) Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, The NetherlandsPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter:聽@JNNP_BMJ聽","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/npnmpugbim3d5ngw/jnnp_170624_distinguishing_CIDP.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/nutritional-peripheral-neuropathies/","name":"Nutritional peripheral neuropathies, with Dr. Alexander Rossor","datePublished":"2024-04-17","description":"The cause of a nutritional neuropathy may not always be obvious when first examining a patient. Restrictive diets with roots in religious practices or personal preferences will be less familiar to neurologists than issues involving bariatric surgery or diseases of malabsorption, and can present as being not overtly malnourished. A recent review in JNNP details links between B-vitamin deficiencies and peripheral neuropathy, and discusses historical trends in the occurrence of nutritional neuropathies. The review's last author, Dr. Alexander Rossor (1), joins host Dr. Saima Chaudhry (2) to talk through how to approach this diagnosis.聽Read the paper here: \"Nutritional peripheral neuropathies\"聽(1) UCL Queen Square Institute of Neurology, London, UK(2) Warren Alpert Medical School, Brown University, Rhode Island, USAPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter:聽@JNNP_BMJ","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/wn8d84/jnnp_190324_nutritional_peripheral_neuropathies.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/distinguishing-primary-from-functional-tics/","name":"Distinguishing primary from functional tics","datePublished":"2024-02-19","description":"How often do movement disorder specialists agree when classifying tics? A recent study published in JNNP explores this question with a two-stage approach, seeking a diagnosis from experts first based on video evidence alone and then following the provision of additional clinical data. The study's last author, Dr. Christos Ganos (1), joins host Dr. Saima Chaudhry (2) to discuss the results.聽Read the paper here: \"Distinguishing functional from primary tics: a study of expert video assessments\"聽聽Related links:European Society for the Study of Tourette Syndrome 2022 criteria for clinical diagnosis of functional tic-like behaviours: International consensus from experts in tic disordershttps://onlinelibrary.wiley.com/doi/10.1111/ene.15672聽Tics and functional tic-like movements: can we tell them apart?https://www.neurology.org/doi/10.1212/WNL.0000000000008372聽聽(1) Department of Neurology (C.G.), Charit茅 University Medicine Berlin, Germany(2) Warren Alpert Medical School, Brown University, Rhode Island, USAPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter:聽@JNNP_BMJ","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/ewuqwq/jnnp_131223_tics.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/nitrous-oxide-induced-myeloneuropathy/","name":"Nitrous Oxide Abuse","datePublished":"2023-09-22","description":"With the UK government announcing plans to make recreational use of nitrous oxide illegal, JNNP podcast host Dr. Saima Chaudhry (1) is joined by London-based neurologist Dr. Alastair Noyce (2)(3) to examine the findings of his group's recently published research paper, \"Nitrous oxide-induced myeloneuropathy: a case series\". Read the paper here: https://jnnp.bmj.com/content/94/9/681Related links:https://www.gov.uk/government/news/nitrous-oxide-to-be-illegal-by-end-of-the-year(1) Warren Alpert Medical School, Brown University, Rhode Island, USA(2) Barts Health NHS Trust, London, UK(3)聽Preventive Neurology Unit, Centre for Prevention, Diagnosis and Detection, Faculty of Medicine and Dentistry, Queen Mary University of London, Wolfson Institute of Population Health, London, UKPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter:聽@JNNP_BMJ","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/pz6dqh/jnnp_110823_NOS.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/brain-fog-demystified/","name":"Brain Fog Demystified","datePublished":"2023-08-08","description":"Social media platforms and clinical patient encounters are abundant in references to brain fog, but how much is it really understood? In this episode, JNNP's podcast host, Dr. Saima Chaudhry (1), speaks with Dr. Laura McWhirter (2) about her recently published article, \"What is Brain Fog?\"and how further understanding of this can help to better treat patients.聽You can read the paper at the following link: https://jnnp.bmj.com/content/94/4/321聽(1) Warren Alpert Medical School, Brown University, Rhode Island, USA(2) Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK聽Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter: @JNNP_BMJ","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/zjjxek/jnnp_170723_brain_fog.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/a-roadmap-to-als-prevention-strategies-and-priorities/","name":"A roadmap to ALS prevention: strategies and priorities","datePublished":"2023-06-15","description":"In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Michael Benatar (2) about his recently published article, \"A roadmap to ALS prevention: strategies and priorities\". This explores a new approach to Amyotrophic lateral sclerosis, with an emphasis on earlier treatment before significant damage has occurred. This is important due to the limited capacity of the central nervous system to repair itself. The researchers involved sought to understand contributing factors for ALS risk, and to identify high-risk groups for further study.Note: The genetic therapy referred to as Tofersen, under review at the time of recording, has been approved by the FDA: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene聽You can read the paper at the following link: https://jnnp.bmj.com/content/94/5/399聽(1) Warren Alpert Medical School, Brown University, Rhode Island, USA(2) Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA聽Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter: @JNNP_BMJ","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/5a8psc/jnnp_060623_ALS_roadmap.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/mogad-definition-diagnosis-and-treatment/","name":"MOGAD: Definition, diagnosis and treatment","datePublished":"2023-05-15","description":"In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, \"Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD\", was recently published in JNNP, and Dr. Gastaldi is its first author. Listen to this podcast to learn what MOGAD is, its differential diagnosis and the potential pathogenesis. Plus some discussion of the use of MOG titres in predicting relapse of the disease. You can read the paper at the following link: https://jnnp.bmj.com/content/94/3/201 (1) Warren Alpert Medical School, Brown University, Rhode Island, USA (2) Neuroimmunology Research Unit, IRCCS Mondino Foundation, Pavia, Italy Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.Follow JNNP on twitter: https://twitter.com/jnnp_bmj","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/ds79w7/stream_1514494804-bmjgroup-mogad-definition-diagnosis-and-treatment.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/cgrp-in-migraine-current-therapeutics-future-implications-and-potential-off-target-effects/","name":"CGRP in migraine: current therapeutics, future implications and potential off-target effects","datePublished":"2021-12-21","description":"In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.Related article: https://jnnp.bmj.com/content/92/12/1325","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/197sp8/stream_1181914012-bmjgroup-cgrp-in-migraine-current-therapeutics-future-implications-and-potential-off-target-effects.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/alemtuzumab-s-impact-on-functional-and-structural-integrity-of-the-visual-system-in-ms/","name":"Alemtuzumab鈥檚 impact on functional and structural integrity of the visual system in MS","datePublished":"2021-11-17","description":"Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS). Prof Barnett discusses his team's results after following up patients with highly active MS for 24 months, using multifocal visual evoked potentials and advanced neuroimaging. He also talks about what this means for future remyelination strategies.Related paper: https://jnnp.bmj.com/content/92/12/1319","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/gixlv8/stream_1161917647-bmjgroup-alemtuzumabs-impact-on-visual-system-in-ms.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}},{"@context":"https://schema.org/","@type":"PodcastEpisode","url":"/e/guidelines-for-the-management-of-functional-speech-and-communication-disorders/","name":"Guidelines for the management of functional speech and communication disorders","datePublished":"2021-09-27","description":"A/Prof Jan Baker, Speech Pathologist, Flinders University and UTS. Dr Laura McWhirter, University of Edinburgh joins editor Colin Mahoney to discuss the first comprehensive guidelines developed to assist speech and language professionals in the management of functional communication, voice, swallow and cough disorders. As part of a global team they have developed a set of clinically focused guidelines in the recognition and management of theses disorders and discuss the highlights on the Podcast. https://jnnp.bmj.com/content/92/10/1112","associatedMedia":{"@type":"MediaObject","contentUrl":"https://mcdn.podbean.com/mf/web/2jcgjk/stream_1131796204-bmjgroup-guidelines-for-the-management-of-functional-speech-and-communication-disorders.mp3"},"partOfSeries":{"@type":"PodcastSeries","name":"JNNP Podcast","url":"https://jnnpbmj.podbean.com"}}]</script><link type="application/rss+xml" rel="alternate" href="https://feed.podbean.com/jnnpbmj/feed.xml" title="JNNP Podcast"><link rel="canonical" href="https://jnnpbmj.podbean.com/"><meta name="head:count" content="32"><link rel="modulepreload" crossorigin href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/list.ad4c1a7e.js"><link rel="stylesheet" href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/list.f36e4a48.css"><link rel="modulepreload" crossorigin href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/HomeHeader.33e3eada.js"><link rel="stylesheet" href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/HomeHeader.154163b6.css"><link rel="modulepreload" crossorigin href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/HeadEpisode.61535100.js"><link rel="stylesheet" href="https://pbcdn1.podbean.com/fs1/user-site-dist/assets/HeadEpisode.2ee78d25.css"> </head> <body data-head-attrs="" > <div id="app" data-server-rendered="true"><div class="main-page main-style-light" style="--font:Avenir;--secondaryFont:Avenir;--playerColor:#679A35;--playerColorRGB:103,154,53;--homeHeaderTextColor:#000000;--homeHeaderBackgroundColor:#ffffff;--pageHeaderTextColor:#ffffff;--pageHeaderBackgroundColor:#868686;"><link rel="stylesheet" href="https://s3.amazonaws.com/user-css.podbean.com/16464412/elegant/style.css" type="text/css"><div class="cc-theme theme-elegant d-flex flex-column h-100 list-page list-page-all"><!--[--><div class="cc-navigation1 navigation" style="--navigationFontColor:#000000;--navigationBackgroundColor:#e9e9e9;"><nav class="navbar navbar-expand-lg"><div class="container justify-content-center"><div style="" class="nav-item search-icon list-unstyled"><button class="btn bg-transparent d-black d-lg-none border-0 nav-link text-dark px-2" type="button" title="Search"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-search" viewbox="0 0 16 16"><path d="M11.742 10.344a6.5 6.5 0 1 0-1.397 1.398h-.001c.03.04.062.078.098.115l3.85 3.85a1 1 0 0 0 1.415-1.414l-3.85-3.85a1.007 1.007 0 0 0-.115-.1zM12 6.5a5.5 5.5 0 1 1-11 0 5.5 5.5 0 0 1 11 0z"></path></svg></button></div><div class="h-search" style="display:none;"><input class="form-control shadow-sm rounded-pill border-0" title="Search" value="" type="text" placeholder="Search"><button type="button" class="btn bg-transparent border-0">Cancel</button></div><button class="navbar-toggler px-2" type="button" title="Navbar toggle" data-bs-toggle="collapse" data-bs-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"><svg xmlns="http://www.w3.org/2000/svg" width="28" height="28" fill="currentColor" class="bi bi-list" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M2.5 12a.5.5 0 0 1 .5-.5h10a.5.5 0 0 1 0 1H3a.5.5 0 0 1-.5-.5zm0-4a.5.5 0 0 1 .5-.5h10a.5.5 0 0 1 0 1H3a.5.5 0 0 1-.5-.5zm0-4a.5.5 0 0 1 .5-.5h10a.5.5 0 0 1 0 1H3a.5.5 0 0 1-.5-.5z"></path></svg></button><div class="collapse navbar-collapse" id="navbarNav"><ul class="navbar-nav" style=""><!--[--><li class="nav-item"><!--[--><a aria-current="page" href="/" class="active router-link-exact-active nav-link"><!--[-->Home<!--]--></a><!--]--></li><li class="nav-item"><!--[--><a target="_blank" rel="noopener noreferrer" class="nav-link" active-class="active" href="https://www.podbean.com/site/podcatcher/index/blog/560MwnTqGugG"><!--[-->Subscribe<!--]--></a><!--]--></li><li class="nav-item"><!--[--><a target="_blank" rel="noopener noreferrer" class="nav-link" active-class="active" href="https://www.podbean.com/user-M9JKloTW5FLG"><!--[-->Profile<!--]--></a><!--]--></li><!--]--><!--[--><li style="" class="nav-item search-icon"><button class="btn bg-transparent border-0 nav-link" type="button" title="Search"><svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" fill="currentColor" class="bi bi-search" viewbox="0 0 16 16"><path d="M11.742 10.344a6.5 6.5 0 1 0-1.397 1.398h-.001c.03.04.062.078.098.115l3.85 3.85a1 1 0 0 0 1.415-1.414l-3.85-3.85a1.007 1.007 0 0 0-.115-.1zM12 6.5a5.5 5.5 0 1 1-11 0 5.5 5.5 0 0 1 11 0z"></path></svg></button></li><!--]--></ul></div></div></nav></div><!----><!--]--><div class="common-content flex-shrink-0 home-page"><!--[--><!----><div class="cc-top-content home-header-bg"><div class="container"><div class="row"><div class="col text-center mb-5 pb-4"><h1 class="mt-5 text-break"><i class="bi-alarm"></i><i class="bi-alarm-clock"></i><i class="bi bi-vinyl-fill"></i> JNNP Podcast</h1><p class="mt-4 pt-2 p-description">The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP鈥檚 ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson鈥檚 disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. Join Dr. Saima Chaudhry as she hosts in-depth interviews with authors, providing a deeper understanding of their work and shedding new light on their findings. Stay informed with expert discussions and cutting-edge information by subscribing or listening on your favourite podcast platform.</p><div class="mt-4"><div class="cc-podcast-apps-content"><p class="fs-18 title">Listen on:</p><ul class="cc-podcast-apps list-unstyled d-flex flex-wrap podcast-app"><!--[--><li class="mb-2"><a href="https://podcasts.apple.com/gb/podcast/jnnp-podcast/id426391174" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="Apple Podcasts"><img class="Apple Podcasts rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png" alt="Apple Podcasts"></a></li><li class="mb-2"><a href="https://r4j68.app.goo.gl/?link=https%3A%2F%2Fjnnpbmj.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog16464412%26podcastIdTag%3De9tb6&dfl=https%3A%2F%2Fjnnpbmj.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="Podbean App"><img class="Podbean App rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png" alt="Podbean App"></a></li><li class="mb-2"><a href="https://open.spotify.com/show/3VHlgiFD3LRw395wBB167T" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="Spotify"><img class="Spotify rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png" alt="Spotify"></a></li><li class="mb-2"><a href="https://music.amazon.com/podcasts/28d7a9ac-cf91-4e3b-9f79-7dbb4f59d48b" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="Amazon Music"><img class="Amazon Music rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/AmazonMusic.png" alt="Amazon Music"></a></li><li class="mb-2"><a href="https://tunein.com/podcasts/JNNP-podcast-p985596" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="TuneIn + Alexa"><img class="TuneIn + Alexa rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/tunein.png" alt="TuneIn + Alexa"></a></li><li class="mb-2"><a href="https://www.iheart.com/podcast/256-jnnp-podcast-30964809/" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="iHeartRadio"><img class="iHeartRadio rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/iHeartRadio.png" alt="iHeartRadio"></a></li><li class="mb-2"><a href="https://player.fm/series/jnnp-podcast-9877" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="PlayerFM"><img class="PlayerFM rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/PlayerFM.png" alt="PlayerFM"></a></li><li class="mb-2"><a href="https://www.listennotes.com/podcasts/jnnp-podcast-bmj-group-zycQJFEt87O/" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="Listen Notes"><img class="Listen Notes rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/ListenNotes.png" alt="Listen Notes"></a></li><li class="mb-2"><a href="https://www.podchaser.com/podcasts/jnnp-podcast-151743" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="Podchaser"><img class="Podchaser rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/Podchaser.webp" alt="Podchaser"></a></li><li class="mb-2"><a href="https://www.boomplaymusic.com/podcasts/82145" class="modal-title" target="_blank" rel="noreferrer noopener" data-bs-toggle="tooltip" data-bs-placement="top" title="BoomPlay"><img class="BoomPlay rounded-circle" src="https://pbcdn1.podbean.com/fs1/site/images/admin5/BoomPlay.png" alt="BoomPlay"></a></li><!--]--></ul></div></div></div></div></div></div><!--]--><div class="cc-customize-container"><!----><!--[--><!--]--><!--teleport start--><!--teleport end--></div><!--[--><!----><div><div class="container list-container"><!--[--><h2 class="text-center cc-episode-title">Episodes</h2><!--]--><div class="episode-list-type-simple-list row row-cols-1 row-cols-md-4 pt-4 g-4 mt-0 episode-content cc-episode-list"><!--[--><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Monday Jul 15, 2024</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/distinguishing-autoimmune-nodopathies-from-cidp/" class="text-decoration-none text-truncate"><!--[-->Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer<!--]--></a></h2><p class="r-t-date text-gray">Monday Jul 15, 2024</p></div></div><p class="e-date text-gray">Monday Jul 15, 2024</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be difficult to distinguish from autoimmune nodopathy. In this podcast, Dr. Saima Chaudhry (1) is joined from the Netherlands by Dr. Ruth Huizinga (2) and Dr. Maarten Titulaer (3), to discuss their article, "Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort". They start with explaining what an autoimmune nodopathy really is, patient features to look out for, and the typical testing process for identifying CIDP.<br>(1) Warren Alpert Medical School, Brown University, Rhode Island, USA<br>(2) Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands<br>(3) Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands<br>Please subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter:聽@JNNP_BMJ<br>聽</p><!----></div><div class="read-more"><a href="/e/distinguishing-autoimmune-nodopathies-from-cidp/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB1648DF4JYBQB" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Wednesday Apr 17, 2024</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Nutritional peripheral neuropathies, with Dr. Alexander Rossor"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Nutritional peripheral neuropathies, with Dr. Alexander Rossor"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/nutritional-peripheral-neuropathies/" class="text-decoration-none text-truncate"><!--[-->Nutritional peripheral neuropathies, with Dr. Alexander Rossor<!--]--></a></h2><p class="r-t-date text-gray">Wednesday Apr 17, 2024</p></div></div><p class="e-date text-gray">Wednesday Apr 17, 2024</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">The cause of a nutritional neuropathy may not always be obvious when first examining a patient. Restrictive diets with roots in religious practices or personal preferences will be less familiar to neurologists than issues involving bariatric surgery or diseases of malabsorption, and can present as being not overtly malnourished. A recent review in JNNP details links between B-vitamin deficiencies and peripheral neuropathy, and discusses historical trends in the occurrence of nutritional neuropathies. The review's last author, Dr. Alexander Rossor (1), joins host Dr. Saima Chaudhry (2) to talk through how to approach this diagnosis.<br>聽<br>Read the paper here: "Nutritional peripheral neuropathies"<br>聽<br>(1) UCL Queen Square Institute of Neurology, London, UK(2) Warren Alpert Medical School, Brown University, Rhode Island, USA<br>Please subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter:聽@JNNP_BMJ</p><!----></div><div class="read-more"><a href="/e/nutritional-peripheral-neuropathies/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB15D814AVXJVR" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Monday Feb 19, 2024</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Distinguishing primary from functional tics"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Distinguishing primary from functional tics"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/distinguishing-primary-from-functional-tics/" class="text-decoration-none text-truncate"><!--[-->Distinguishing primary from functional tics<!--]--></a></h2><p class="r-t-date text-gray">Monday Feb 19, 2024</p></div></div><p class="e-date text-gray">Monday Feb 19, 2024</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">How often do movement disorder specialists agree when classifying tics? A recent study published in JNNP explores this question with a two-stage approach, seeking a diagnosis from experts first based on video evidence alone and then following the provision of additional clinical data. The study's last author, Dr. Christos Ganos (1), joins host Dr. Saima Chaudhry (2) to discuss the results.<br>聽<br>Read the paper here: "Distinguishing functional from primary tics: a study of expert video assessments"聽<br>聽<br>Related links:<br>European Society for the Study of Tourette Syndrome 2022 criteria for clinical diagnosis of functional tic-like behaviours: International consensus from experts in tic disordershttps://onlinelibrary.wiley.com/doi/10.1111/ene.15672<br>聽<br>Tics and functional tic-like movements: can we tell them apart?https://www.neurology.org/doi/10.1212/WNL.0000000000008372聽<br>聽<br>(1) Department of Neurology (C.G.), Charit茅 University Medicine Berlin, Germany(2) Warren Alpert Medical School, Brown University, Rhode Island, USA<br>Please subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter:聽@JNNP_BMJ</p><!----></div><div class="read-more"><a href="/e/distinguishing-primary-from-functional-tics/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB155440B8ZR4P" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Friday Sep 22, 2023</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Nitrous Oxide Abuse"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Nitrous Oxide Abuse"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/nitrous-oxide-induced-myeloneuropathy/" class="text-decoration-none text-truncate"><!--[-->Nitrous Oxide Abuse<!--]--></a></h2><p class="r-t-date text-gray">Friday Sep 22, 2023</p></div></div><p class="e-date text-gray">Friday Sep 22, 2023</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">With the UK government announcing plans to make recreational use of nitrous oxide illegal, JNNP podcast host Dr. Saima Chaudhry (1) is joined by London-based neurologist Dr. Alastair Noyce (2)(3) to examine the findings of his group's recently published research paper, "Nitrous oxide-induced myeloneuropathy: a case series". Read the paper here: https://jnnp.bmj.com/content/94/9/681<br>Related links:<br>https://www.gov.uk/government/news/nitrous-oxide-to-be-illegal-by-end-of-the-year(1) Warren Alpert Medical School, Brown University, Rhode Island, USA(2) Barts Health NHS Trust, London, UK(3)聽Preventive Neurology Unit, Centre for Prevention, Diagnosis and Detection, Faculty of Medicine and Dentistry, Queen Mary University of London, Wolfson Institute of Population Health, London, UK<br>Please subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter:聽@JNNP_BMJ</p><!----></div><div class="read-more"><a href="/e/nitrous-oxide-induced-myeloneuropathy/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB14AAEEBF89TU" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Tuesday Aug 08, 2023</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Brain Fog Demystified"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Brain Fog Demystified"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/brain-fog-demystified/" class="text-decoration-none text-truncate"><!--[-->Brain Fog Demystified<!--]--></a></h2><p class="r-t-date text-gray">Tuesday Aug 08, 2023</p></div></div><p class="e-date text-gray">Tuesday Aug 08, 2023</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">Social media platforms and clinical patient encounters are abundant in references to brain fog, but how much is it really understood? In this episode, JNNP's podcast host, Dr. Saima Chaudhry (1), speaks with Dr. Laura McWhirter (2) about her recently published article, "What is Brain Fog?"and how further understanding of this can help to better treat patients.聽<br>You can read the paper at the following link: https://jnnp.bmj.com/content/94/4/321聽<br>(1) Warren Alpert Medical School, Brown University, Rhode Island, USA<br>(2) Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK<br>聽<br>Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter: @JNNP_BMJ</p><!----></div><div class="read-more"><a href="/e/brain-fog-demystified/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB146EC39WDRNX" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Thursday Jun 15, 2023</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play A roadmap to ALS prevention: strategies and priorities"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play A roadmap to ALS prevention: strategies and priorities"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/a-roadmap-to-als-prevention-strategies-and-priorities/" class="text-decoration-none text-truncate"><!--[-->A roadmap to ALS prevention: strategies and priorities<!--]--></a></h2><p class="r-t-date text-gray">Thursday Jun 15, 2023</p></div></div><p class="e-date text-gray">Thursday Jun 15, 2023</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Michael Benatar (2) about his recently published article, "A roadmap to ALS prevention: strategies and priorities". This explores a new approach to Amyotrophic lateral sclerosis, with an emphasis on earlier treatment before significant damage has occurred. This is important due to the limited capacity of the central nervous system to repair itself. The researchers involved sought to understand contributing factors for ALS risk, and to identify high-risk groups for further study.<br>Note: The genetic therapy referred to as Tofersen, under review at the time of recording, has been approved by the FDA: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene聽<br>You can read the paper at the following link: https://jnnp.bmj.com/content/94/5/399聽<br>(1) Warren Alpert Medical School, Brown University, Rhode Island, USA<br>(2) Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA<br>聽<br>Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter: @JNNP_BMJ</p><!----></div><div class="read-more"><a href="/e/a-roadmap-to-als-prevention-strategies-and-priorities/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB1434786CZS7Z" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Monday May 15, 2023</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play MOGAD: Definition, diagnosis and treatment"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play MOGAD: Definition, diagnosis and treatment"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/mogad-definition-diagnosis-and-treatment/" class="text-decoration-none text-truncate"><!--[-->MOGAD: Definition, diagnosis and treatment<!--]--></a></h2><p class="r-t-date text-gray">Monday May 15, 2023</p></div></div><p class="e-date text-gray">Monday May 15, 2023</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, "Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD", was recently published in JNNP, and Dr. Gastaldi is its first author. Listen to this podcast to learn what MOGAD is, its differential diagnosis and the potential pathogenesis. Plus some discussion of the use of MOG titres in predicting relapse of the disease. You can read the paper at the following link: https://jnnp.bmj.com/content/94/3/201 (1) Warren Alpert Medical School, Brown University, Rhode Island, USA (2) Neuroimmunology Research Unit, IRCCS Mondino Foundation, Pavia, Italy Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.<br>Follow JNNP on twitter: https://twitter.com/jnnp_bmj</p><!----></div><div class="read-more"><a href="/e/mogad-definition-diagnosis-and-treatment/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB140D90AXMH6W" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Tuesday Dec 21, 2021</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play CGRP in migraine: current therapeutics, future implications and potential off-target effects"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play CGRP in migraine: current therapeutics, future implications and potential off-target effects"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/cgrp-in-migraine-current-therapeutics-future-implications-and-potential-off-target-effects/" class="text-decoration-none text-truncate"><!--[-->CGRP in migraine: current therapeutics, future implications and potential off-target effects<!--]--></a></h2><p class="r-t-date text-gray">Tuesday Dec 21, 2021</p></div></div><p class="e-date text-gray">Tuesday Dec 21, 2021</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.<br>Related article: https://jnnp.bmj.com/content/92/12/1325</p><!----></div><div class="read-more"><a href="/e/cgrp-in-migraine-current-therapeutics-future-implications-and-potential-off-target-effects/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB140D90BM8VP3" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Wednesday Nov 17, 2021</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Alemtuzumab鈥檚 impact on functional and structural integrity of the visual system in MS"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Alemtuzumab鈥檚 impact on functional and structural integrity of the visual system in MS"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/alemtuzumab-s-impact-on-functional-and-structural-integrity-of-the-visual-system-in-ms/" class="text-decoration-none text-truncate"><!--[-->Alemtuzumab鈥檚 impact on functional and structural integrity of the visual system in MS<!--]--></a></h2><p class="r-t-date text-gray">Wednesday Nov 17, 2021</p></div></div><p class="e-date text-gray">Wednesday Nov 17, 2021</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS). <br>Prof Barnett discusses his team's results after following up patients with highly active MS for 24 months, using multifocal visual evoked potentials and advanced neuroimaging. He also talks about what this means for future remyelination strategies.<br>Related paper: https://jnnp.bmj.com/content/92/12/1319</p><!----></div><div class="read-more"><a href="/e/alemtuzumab-s-impact-on-functional-and-structural-integrity-of-the-visual-system-in-ms/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB140D90CBTNWR" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><div class="col6 mt-0 card bg-transparent border-0 d-md-flex list"><div class="episode-logo position-relative" href="javascript:void(0)"><!----><p class="e-l-date">Monday Sep 27, 2021</p><div class="hover-bg"></div><div class="play-bg position-absolute d-flex align-items-center justify-content-center"><button type="button" class="btn btn-link play-button" title="Play Guidelines for the management of functional speech and communication disorders"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button></div></div><div class="card-body position-relative"><div class="card-body-button-title"><button type="button" class="btn btn-link play-button e-r-play-button" title="Play Guidelines for the management of functional speech and communication disorders"><span class="play-button-bg"><svg t="1622017593702" class="icon icon-play" fill="currentColor" viewbox="0 0 1024 1024" version="1.1" xmlns="http://www.w3.org/2000/svg" p-id="12170" width="30" height="30"><path d="M844.704269 475.730473L222.284513 116.380385a43.342807 43.342807 0 0 0-65.025048 37.548353v718.692951a43.335582 43.335582 0 0 0 65.025048 37.541128l622.412531-359.342864a43.357257 43.357257 0 0 0 0.007225-75.08948z" fill="" p-id="12171"></path></svg></span></button><div class="right-title-date"><h2 class="card-title e-title text-truncate"><a href="/e/guidelines-for-the-management-of-functional-speech-and-communication-disorders/" class="text-decoration-none text-truncate"><!--[-->Guidelines for the management of functional speech and communication disorders<!--]--></a></h2><p class="r-t-date text-gray">Monday Sep 27, 2021</p></div></div><p class="e-date text-gray">Monday Sep 27, 2021</p><!--[--><div class="episode-description"><p class="e-description text-two-line card-text">A/Prof Jan Baker, Speech Pathologist, Flinders University and UTS. Dr Laura McWhirter, University of Edinburgh joins editor Colin Mahoney to discuss the first comprehensive guidelines developed to assist speech and language professionals in the management of functional communication, voice, swallow and cough disorders. As part of a global team they have developed a set of clinically focused guidelines in the recognition and management of theses disorders and discuss the highlights on the Podcast. https://jnnp.bmj.com/content/92/10/1112</p><!----></div><div class="read-more"><a href="/e/guidelines-for-the-management-of-functional-speech-and-communication-disorders/" class="text-decoration-none text-truncate"><!--[--> Read more <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-right" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M1 8a.5.5 0 0 1 .5-.5h11.793l-3.147-3.146a.5.5 0 0 1 .708-.708l4 4a.5.5 0 0 1 0 .708l-4 4a.5.5 0 0 1-.708-.708L13.293 8.5H1.5A.5.5 0 0 1 1 8z"></path></svg><!--]--></a></div><!--]--><div class="cc-post-toolbar"><ul class="list-unstyled d-flex mb-0 row gx-5 p-0"><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Likes" data-bs-toggle="modal" data-bs-target="#likeModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-heart col-auto icon-like" viewbox="0 0 16 16"><path d="m8 2.748-.717-.737C5.6.281 2.514.878 1.4 3.053c-.523 1.023-.641 2.5.314 4.385.92 1.815 2.834 3.989 6.286 6.357 3.452-2.368 5.365-4.542 6.286-6.357.955-1.886.838-3.362.314-4.385C13.486.878 10.4.28 8.717 2.01L8 2.748zM8 15C-7.333 4.868 3.279-3.04 7.824 1.143c.06.055.119.112.176.171a3.12 3.12 0 0 1 .176-.17C12.72-3.042 23.333 4.867 8 15z"></path></svg><span class="text-gray col-auto item-name">Likes</span><!----></button></li><li class="col-auto"><a class="border-0 p-0 bg-transparent row gx-1 align-items-center" href="https://www.podbean.com/site/EpisodeDownload/PB140D90ET6YD6" target="_blank" title="Download"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-arrow-down-square col-auto" viewbox="0 0 16 16"><path fill-rule="evenodd" d="M15 2a1 1 0 0 0-1-1H2a1 1 0 0 0-1 1v12a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1V2zM0 2a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v12a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V2zm8.5 2.5a.5.5 0 0 0-1 0v5.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V4.5z"></path></svg><span class="text-gray col-auto item-name">Download</span><!----></a></li><li class="col-auto"><button class="border-0 p-0 bg-transparent row gx-1 align-items-center" title="Share" data-bs-toggle="modal" data-bs-target="#shareModal"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="currentColor" class="bi bi-share col-auto" viewbox="0 0 16 16"><path d="M13.5 1a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zM11 2.5a2.5 2.5 0 1 1 .603 1.628l-6.718 3.12a2.499 2.499 0 0 1 0 1.504l6.718 3.12a2.5 2.5 0 1 1-.488.876l-6.718-3.12a2.5 2.5 0 1 1 0-3.256l6.718-3.12A2.5 2.5 0 0 1 11 2.5zm-8.5 4a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3zm11 5.5a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3z"></path></svg><span class="text-gray item-name col-auto">Share</span></button></li></ul></div></div></div><!--]--></div><div class="row text-center load-more cc-pagination2 pt-3 pb-5"><a href="/page/2/" class="p-2 text-decoration-none"><!--[-->Load more<!--]--></a></div></div></div><!--]--><div class="cc-customize-container"><!----><!--[--><div style="--componentBackgroundColor:#f2f2f2;--componentFontColor:#000000;" class="cc-customize-text pb-4 pt-4"><div class="customize-bg"><div class="container"><div class="row"><div class="col text-center"><div class="text"><div style="text-align: center;"> <div style="text-align: center;"> <p ><em >The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner鈥檚 judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.</em></p> </div> </div></div></div></div></div></div><!--[--><!--]--><!--teleport start--><!--teleport end--></div><!--]--><!--teleport start--><!--teleport end--></div></div><!--[--><footer class="cc-footer2 footer mt-auto" style="--footerFontColor:#ffffff;--footerBackgroundColor:#000000;"><div class="container text-center"><ul class="row gx-4 social-icon-content list-unstyled d-flex justify-content-center mb-0"><!----><!----><!----><!----><!----></ul><div class="right-content"><p class="mb-0 pt-3">Copyright 2023 All rights reserved.</p><!----></div></div></footer><div class="after-footer"></div><!----><!--]--></div><!----><!----><!----><div style="display:none;">Version: 20241125</div></div></div> <script>window.__INITIAL_STATE__="{\"store\":{\"baseInfo\":{\"podcastTitle\":\"JNNP Podcast\",\"slug\":\"jnnpbmj\",\"podcastDescription\":\"The Journal of Neurology, Neuroscience and Psychiatry (JNNP) Podcast is proud to reflect JNNP鈥檚 ambition to publish the most ground-breaking and cutting-edge research from around the world - jnnp.bmj.com. \\nEncompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson鈥檚 disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.\\n\\nJoin Dr. Saima Chaudhry as she hosts in-depth interviews with authors, providing a deeper understanding of their work and shedding new light on their findings. Stay informed with expert discussions and cutting-edge information by subscribing or listening on your favourite podcast platform.\",\"podcastLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"podcastShareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"podcastUrl\":\"https:\u002F\u002Fjnnpbmj.podbean.com\",\"podcastCanSearched\":true,\"feedUrl\":\"https:\u002F\u002Ffeed.podbean.com\u002Fjnnpbmj\u002Ffeed.xml\",\"theme\":\"elegant\",\"podcastDeepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fpu\u002Fpbblog-e9tb6-fb3a1c\",\"removePodbeanBranding\":\"yes\",\"brandingLogo\":null,\"timeZone\":{\"timeZoneId\":30,\"gmtAdjustment\":\"GMT+00:00\",\"useDaylightTime\":1,\"value\":0,\"text\":\"(GMT+00:00) Greenwich Mean Time : Dublin, Edinburgh, Lisbon, London\",\"daylightStartTime\":\"Last Sunday of March +1 Hours\",\"daylightEndTime\":\"Last Sunday Of October +1 Hours\",\"timezone\":\"Europe\u002FLondon\"},\"podcastDownloads\":null,\"totalEpisodes\":177,\"showComments\":false,\"iOSAppDownloadLink\":null,\"customizeCssUrl\":\"https:\u002F\u002Fs3.amazonaws.com\u002Fuser-css.podbean.com\u002F16464412\u002Felegant\u002Fstyle.css\",\"androidAppDownloadLink\":null,\"showPostShare\":true,\"showLike\":true,\"author\":\"BMJ Group\",\"engagementStatsBaseUrl\":null,\"shareEmbedLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pbblog-e9tb6-fb3a1c-playlist\",\"language\":\"en\",\"sensitivitySessionExpireTime\":3600,\"podcastApps\":[{\"name\":\"Apple Podcasts\",\"link\":\"https:\u002F\u002Fpodcasts.apple.com\u002Fgb\u002Fpodcast\u002Fjnnp-podcast\u002Fid426391174\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002Fapple-podcast.png\",\"title\":null},{\"name\":\"Podbean App\",\"link\":\"https:\u002F\u002Fr4j68.app.goo.gl\u002F?link=https%3A%2F%2Fjnnpbmj.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog16464412%26podcastIdTag%3De9tb6&dfl=https%3A%2F%2Fjnnpbmj.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002Fpodbean-app.png\",\"title\":null},{\"name\":\"Spotify\",\"link\":\"https:\u002F\u002Fopen.spotify.com\u002Fshow\u002F3VHlgiFD3LRw395wBB167T\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002Fspotify.png\",\"title\":null},{\"name\":\"Amazon Music\",\"link\":\"https:\u002F\u002Fmusic.amazon.com\u002Fpodcasts\u002F28d7a9ac-cf91-4e3b-9f79-7dbb4f59d48b\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002FAmazonMusic.png\",\"title\":null},{\"name\":\"TuneIn + Alexa\",\"link\":\"https:\u002F\u002Ftunein.com\u002Fpodcasts\u002FJNNP-podcast-p985596\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002Ftunein.png\",\"title\":null},{\"name\":\"iHeartRadio\",\"link\":\"https:\u002F\u002Fwww.iheart.com\u002Fpodcast\u002F256-jnnp-podcast-30964809\u002F\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002FiHeartRadio.png\",\"title\":null},{\"name\":\"PlayerFM\",\"link\":\"https:\u002F\u002Fplayer.fm\u002Fseries\u002Fjnnp-podcast-9877\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002FPlayerFM.png\",\"title\":null},{\"name\":\"Listen Notes\",\"link\":\"https:\u002F\u002Fwww.listennotes.com\u002Fpodcasts\u002Fjnnp-podcast-bmj-group-zycQJFEt87O\u002F\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002FListenNotes.png\",\"title\":null},{\"name\":\"Podchaser\",\"link\":\"https:\u002F\u002Fwww.podchaser.com\u002Fpodcasts\u002Fjnnp-podcast-151743\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002FPodchaser.webp\",\"title\":null},{\"name\":\"BoomPlay\",\"link\":\"https:\u002F\u002Fwww.boomplaymusic.com\u002Fpodcasts\u002F82145\",\"image\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\u002Fsite\u002Fimages\u002Fadmin5\u002FBoomPlay.png\",\"title\":null}],\"components\":{\"base\":[{\"id\":\"MainStyle\",\"val\":\"light\"},{\"id\":\"Font\",\"val\":\"Avenir\"},{\"id\":\"SecondaryFont\",\"val\":\"Avenir\"},{\"id\":\"PlayerColor\",\"val\":\"#679A35\"},{\"id\":\"PlayerStyle\",\"val\":\"player1\"},{\"id\":\"PlayerWave\",\"val\":\"hide\"},{\"id\":\"Favicon\",\"val\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fc3v67p\u002FJNNP.jpg\"},{\"id\":\"CookiesNotice\",\"val\":\"hide\"},{\"id\":\"CookiesNoticeContent\",\"val\":\"\u003Ch2\u003ECookies Notice\u003C\u002Fh2\u003E\u003Cp\u003EThis website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.\u003C\u002Fp\u003E\"}],\"home-header\":[{\"id\":\"HomeHeaderTextColor\",\"val\":\"#000000\"},{\"id\":\"HomeHeaderBackgroundColor\",\"val\":\"#ffffff\"}],\"page-header\":[{\"id\":\"PageHeaderTextColor\",\"val\":\"#ffffff\"},{\"id\":\"PageHeaderBackgroundColor\",\"val\":\"#868686\"}],\"episode-list\":[{\"id\":\"EpisodeListType\",\"val\":\"simple-list\"},{\"id\":\"EpisodesPerPage\",\"val\":10},{\"id\":\"EpisodeStats\",\"val\":\"hide\"}],\"navigation\":[{\"id\":\"NavigationFontColor\",\"val\":\"#000000\"},{\"id\":\"NavigationBackgroundColor\",\"val\":\"#e9e9e9\"},{\"id\":\"NavigationSearch\",\"val\":\"show\"},{\"id\":\"NavigationLinks\",\"val\":[{\"id\":\"Home\",\"type\":\"Link\",\"value\":\"\u002F\",\"text\":\"Home\",\"subitems\":[]},{\"id\":\"Subscribe\",\"type\":\"Link\",\"value\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002Fpodcatcher\u002Findex\u002Fblog\u002F560MwnTqGugG\",\"text\":\"Subscribe\",\"subitems\":[]},{\"id\":\"Profile\",\"type\":\"Link\",\"value\":\"https:\u002F\u002Fwww.podbean.com\u002Fuser-M9JKloTW5FLG\",\"text\":\"Profile\",\"subitems\":[]}]}],\"footer\":[{\"id\":\"FooterType\",\"val\":\"Footer2\"},{\"id\":\"FooterFontColor\",\"val\":\"#ffffff\"},{\"id\":\"FooterBackgroundColor\",\"val\":\"#000000\"},{\"id\":\"FooterCopyright\",\"val\":\"Copyright 2023 All rights reserved.\"},{\"id\":\"SocialMediaLinks\",\"val\":{\"facebook_username\":\"\",\"twitter_username\":\"\",\"instagram_username\":\"\",\"youtube_username\":\"\",\"linkedin_username\":\"\"}}],\"customize-container1\":[],\"customize-container2\":[{\"id\":\"ComponentText-ccb1c38c-9993-ad98-0ccc-b942d2290eae\",\"val\":{\"ComponentFontColor\":\"#000000\",\"ComponentBackgroundColor\":\"#f2f2f2\",\"ComponentContent\":\"\u003Cdiv style=\\\"text-align: center;\\\"\u003E\\n\u003Cdiv style=\\\"text-align: center;\\\"\u003E\\n\u003Cp\u003E\u003Cem\u003EThe purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner鈥檚 judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.\u003C\u002Fem\u003E\u003C\u002Fp\u003E\\n\u003C\u002Fdiv\u003E\\n\u003C\u002Fdiv\u003E\"}}]},\"allLinks\":[],\"mainStylesDefaultSettings\":null,\"defaultCustomizeComponents\":null,\"scripts\":[],\"metas\":null,\"appConfig\":{\"package\":\"com.podbean.app.generic\",\"app_store_id\":1484287462,\"app_name\":\"Podbean Biz Podcast App\",\"scheme\":\"enterprise-podbean-com\"},\"customizeCss\":null,\"canEditCss\":null,\"enableJsCodeInCustomizeContent\":false,\"enabledIframeCodeInCustomizeContent\":true,\"sectionMaxCount\":10,\"enableEditorLink\":true,\"enableEditCookiesNotice\":true,\"siteRedirectToFeed\":false,\"podcatcherRssUrl\":null,\"showFeed\":true,\"showTopBar\":false,\"enableWebSiteLike\":false,\"organizationName\":\"BMJ Podcasts\",\"organizationPageLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fpodcast-network\u002FBMJPodcasts\"},\"backToListUrl\":\"\u002F\",\"tinymceLoaded\":false,\"listEpisodes\":[{\"id\":\"pb23367156\",\"idTag\":\"jybqb\",\"title\":\"Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be difficult to distinguish from autoimmune nodopathy. In this podcast, Dr. Saima Chaudhry (1) is joined from the Netherlands by Dr. Ruth Huizinga (2) and Dr. Maarten Titulaer (3), to discuss their article, \\\"Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort\\\". They start with explaining what an autoimmune nodopathy really is, patient features to look out for, and the typical testing process for identifying CIDP.\u003Cbr\u003E(1) Warren Alpert Medical School, Brown University, Rhode Island, USA\u003Cbr\u003E(2) Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands\u003Cbr\u003E(3) Department of Neurology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands\u003Cbr\u003EPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter:聽@JNNP_BMJ\u003Cbr\u003E聽\",\"content\":null,\"publishTimestamp\":1721037796,\"duration\":2337,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fnpnmpugbim3d5ngw\u002Fjnnp_170624_distinguishing_CIDP.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-jybqb-1648df4\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-jybqb-1648df4\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fdistinguishing-autoimmune-nodopathies-from-cidp\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB1648DF4JYBQB\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb22905162\",\"idTag\":\"vxjvr\",\"title\":\"Nutritional peripheral neuropathies, with Dr. Alexander Rossor\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"The cause of a nutritional neuropathy may not always be obvious when first examining a patient. Restrictive diets with roots in religious practices or personal preferences will be less familiar to neurologists than issues involving bariatric surgery or diseases of malabsorption, and can present as being not overtly malnourished. A recent review in JNNP details links between B-vitamin deficiencies and peripheral neuropathy, and discusses historical trends in the occurrence of nutritional neuropathies. The review's last author, Dr. Alexander Rossor (1), joins host Dr. Saima Chaudhry (2) to talk through how to approach this diagnosis.\u003Cbr\u003E聽\u003Cbr\u003ERead the paper here: \\\"Nutritional peripheral neuropathies\\\"\u003Cbr\u003E聽\u003Cbr\u003E(1) UCL Queen Square Institute of Neurology, London, UK(2) Warren Alpert Medical School, Brown University, Rhode Island, USA\u003Cbr\u003EPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter:聽@JNNP_BMJ\",\"content\":null,\"publishTimestamp\":1713326400,\"duration\":2382,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fwn8d84\u002Fjnnp_190324_nutritional_peripheral_neuropathies.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-vxjvr-15d814a\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-vxjvr-15d814a\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fnutritional-peripheral-neuropathies\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB15D814AVXJVR\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb22365195\",\"idTag\":\"8zr4p\",\"title\":\"Distinguishing primary from functional tics\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"How often do movement disorder specialists agree when classifying tics? A recent study published in JNNP explores this question with a two-stage approach, seeking a diagnosis from experts first based on video evidence alone and then following the provision of additional clinical data. The study's last author, Dr. Christos Ganos (1), joins host Dr. Saima Chaudhry (2) to discuss the results.\u003Cbr\u003E聽\u003Cbr\u003ERead the paper here: \\\"Distinguishing functional from primary tics: a study of expert video assessments\\\"聽\u003Cbr\u003E聽\u003Cbr\u003ERelated links:\u003Cbr\u003EEuropean Society for the Study of Tourette Syndrome 2022 criteria for clinical diagnosis of functional tic-like behaviours: International consensus from experts in tic disordershttps:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fene.15672\u003Cbr\u003E聽\u003Cbr\u003ETics and functional tic-like movements: can we tell them apart?https:\u002F\u002Fwww.neurology.org\u002Fdoi\u002F10.1212\u002FWNL.0000000000008372聽\u003Cbr\u003E聽\u003Cbr\u003E(1) Department of Neurology (C.G.), Charit茅 University Medicine Berlin, Germany(2) Warren Alpert Medical School, Brown University, Rhode Island, USA\u003Cbr\u003EPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter:聽@JNNP_BMJ\",\"content\":null,\"publishTimestamp\":1708318800,\"duration\":2402,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fewuqwq\u002Fjnnp_131223_tics.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-8zr4p-155440b\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-8zr4p-155440b\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fdistinguishing-primary-from-functional-tics\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB155440B8ZR4P\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21671659\",\"idTag\":\"f89tu\",\"title\":\"Nitrous Oxide Abuse\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"With the UK government announcing plans to make recreational use of nitrous oxide illegal, JNNP podcast host Dr. Saima Chaudhry (1) is joined by London-based neurologist Dr. Alastair Noyce (2)(3) to examine the findings of his group's recently published research paper, \\\"Nitrous oxide-induced myeloneuropathy: a case series\\\". Read the paper here: https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F94\u002F9\u002F681\u003Cbr\u003ERelated links:\u003Cbr\u003Ehttps:\u002F\u002Fwww.gov.uk\u002Fgovernment\u002Fnews\u002Fnitrous-oxide-to-be-illegal-by-end-of-the-year(1) Warren Alpert Medical School, Brown University, Rhode Island, USA(2) Barts Health NHS Trust, London, UK(3)聽Preventive Neurology Unit, Centre for Prevention, Diagnosis and Detection, Faculty of Medicine and Dentistry, Queen Mary University of London, Wolfson Institute of Population Health, London, UK\u003Cbr\u003EPlease subscribe to the show on聽Apple Podcasts,聽Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter:聽@JNNP_BMJ\",\"content\":null,\"publishTimestamp\":1695372878,\"duration\":1665,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fpz6dqh\u002Fjnnp_110823_NOS.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-f89tu-14aaeeb\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-f89tu-14aaeeb\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fnitrous-oxide-induced-myeloneuropathy\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB14AAEEBF89TU\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21425209\",\"idTag\":\"wdrnx\",\"title\":\"Brain Fog Demystified\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"Social media platforms and clinical patient encounters are abundant in references to brain fog, but how much is it really understood? In this episode, JNNP's podcast host, Dr. Saima Chaudhry (1), speaks with Dr. Laura McWhirter (2) about her recently published article, \\\"What is Brain Fog?\\\"and how further understanding of this can help to better treat patients.聽\u003Cbr\u003EYou can read the paper at the following link: https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F94\u002F4\u002F321聽\u003Cbr\u003E(1) Warren Alpert Medical School, Brown University, Rhode Island, USA\u003Cbr\u003E(2) Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK\u003Cbr\u003E聽\u003Cbr\u003EPlease subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter: @JNNP_BMJ\",\"content\":null,\"publishTimestamp\":1691485738,\"duration\":1815,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fzjjxek\u002Fjnnp_170723_brain_fog.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-wdrnx-146ec39\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-wdrnx-146ec39\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fbrain-fog-demystified\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB146EC39WDRNX\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21186438\",\"idTag\":\"czs7z\",\"title\":\"A roadmap to ALS prevention: strategies and priorities\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Michael Benatar (2) about his recently published article, \\\"A roadmap to ALS prevention: strategies and priorities\\\". This explores a new approach to Amyotrophic lateral sclerosis, with an emphasis on earlier treatment before significant damage has occurred. This is important due to the limited capacity of the central nervous system to repair itself. The researchers involved sought to understand contributing factors for ALS risk, and to identify high-risk groups for further study.\u003Cbr\u003ENote: The genetic therapy referred to as Tofersen, under review at the time of recording, has been approved by the FDA: https:\u002F\u002Fwww.fda.gov\u002Fdrugs\u002Fnews-events-human-drugs\u002Ffda-approves-treatment-amyotrophic-lateral-sclerosis-associated-mutation-sod1-gene聽\u003Cbr\u003EYou can read the paper at the following link: https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F94\u002F5\u002F399聽\u003Cbr\u003E(1) Warren Alpert Medical School, Brown University, Rhode Island, USA\u003Cbr\u003E(2) Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA\u003Cbr\u003E聽\u003Cbr\u003EPlease subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter: @JNNP_BMJ\",\"content\":null,\"publishTimestamp\":1686841652,\"duration\":2309,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002F5a8psc\u002Fjnnp_060623_ALS_roadmap.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-czs7z-1434786\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-czs7z-1434786\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fa-roadmap-to-als-prevention-strategies-and-priorities\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB1434786CZS7Z\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21027082\",\"idTag\":\"xmh6w\",\"title\":\"MOGAD: Definition, diagnosis and treatment\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, \\\"Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD\\\", was recently published in JNNP, and Dr. Gastaldi is its first author. Listen to this podcast to learn what MOGAD is, its differential diagnosis and the potential pathogenesis. Plus some discussion of the use of MOG titres in predicting relapse of the disease. You can read the paper at the following link: https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F94\u002F3\u002F201 (1) Warren Alpert Medical School, Brown University, Rhode Island, USA (2) Neuroimmunology Research Unit, IRCCS Mondino Foundation, Pavia, Italy Please subscribe to the show on Apple Podcasts, Spotify聽or find it on your platform of choice. Your feedback and reviews are very appreciated.\u003Cbr\u003EFollow JNNP on twitter: https:\u002F\u002Ftwitter.com\u002Fjnnp_bmj\",\"content\":null,\"publishTimestamp\":1684149120,\"duration\":1277,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fds79w7\u002Fstream_1514494804-bmjgroup-mogad-definition-diagnosis-and-treatment.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-xmh6w-140d90a\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-xmh6w-140d90a\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fmogad-definition-diagnosis-and-treatment\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB140D90AXMH6W\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21027083\",\"idTag\":\"m8vp3\",\"title\":\"CGRP in migraine: current therapeutics, future implications and potential off-target effects\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the growing body of evidence for the role of therapies directed against this protein in migraine and beyond. He also highlights emerging off-target side effects to monitor for.\u003Cbr\u003ERelated article: https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F92\u002F12\u002F1325\",\"content\":null,\"publishTimestamp\":1640115180,\"duration\":601,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002F197sp8\u002Fstream_1181914012-bmjgroup-cgrp-in-migraine-current-therapeutics-future-implications-and-potential-off-target-effects.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-m8vp3-140d90b\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-m8vp3-140d90b\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fcgrp-in-migraine-current-therapeutics-future-implications-and-potential-off-target-effects\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB140D90BM8VP3\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21027084\",\"idTag\":\"btnwr\",\"title\":\"Alemtuzumab鈥檚 impact on functional and structural integrity of the visual system in MS\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the most commonly involved neurological pathways, the visual system, in multiple sclerosis (MS). \u003Cbr\u003EProf Barnett discusses his team's results after following up patients with highly active MS for 24 months, using multifocal visual evoked potentials and advanced neuroimaging. He also talks about what this means for future remyelination strategies.\u003Cbr\u003ERelated paper: https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F92\u002F12\u002F1319\",\"content\":null,\"publishTimestamp\":1637165340,\"duration\":1202,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002Fgixlv8\u002Fstream_1161917647-bmjgroup-alemtuzumabs-impact-on-visual-system-in-ms.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-btnwr-140d90c\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-btnwr-140d90c\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Falemtuzumab-s-impact-on-functional-and-structural-integrity-of-the-visual-system-in-ms\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB140D90CBTNWR\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null},{\"id\":\"pb21027086\",\"idTag\":\"t6yd6\",\"title\":\"Guidelines for the management of functional speech and communication disorders\",\"logo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP_300x300.jpg\",\"shareLogo\":\"https:\u002F\u002Fd2bwo9zemjwxh5.cloudfront.net\u002Fimage-logo\u002F16464412\u002FJNNP_1200x628.jpg?s=517ed002d53961c3b6101b584e8454fc&e=jpg\",\"largeLogo\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Fimglogo\u002Fimage-logo\u002F16464412\u002FJNNP.jpg\",\"previewContent\":\"A\u002FProf Jan Baker, Speech Pathologist, Flinders University and UTS. Dr Laura McWhirter, University of Edinburgh joins editor Colin Mahoney to discuss the first comprehensive guidelines developed to assist speech and language professionals in the management of functional communication, voice, swallow and cough disorders. As part of a global team they have developed a set of clinically focused guidelines in the recognition and management of theses disorders and discuss the highlights on the Podcast. https:\u002F\u002Fjnnp.bmj.com\u002Fcontent\u002F92\u002F10\u002F1112\",\"content\":null,\"publishTimestamp\":1632740160,\"duration\":1389,\"mediaUrl\":\"https:\u002F\u002Fmcdn.podbean.com\u002Fmf\u002Fweb\u002F2jcgjk\u002Fstream_1131796204-bmjgroup-guidelines-for-the-management-of-functional-speech-and-communication-disorders.mp3\",\"mediaType\":\"audio\u002Fmpeg\",\"shareLink\":\"https:\u002F\u002Fadmin5.podbean.com\u002Fembed.html?id=pb-t6yd6-140d90e\",\"likedCount\":null,\"deepLink\":\"https:\u002F\u002Fwww.podbean.com\u002Few\u002Fpb-t6yd6-140d90e\",\"transcriptUrl\":null,\"permalink\":\"\u002Fe\u002Fguidelines-for-the-management-of-functional-speech-and-communication-disorders\u002F\",\"downloadLink\":\"https:\u002F\u002Fwww.podbean.com\u002Fsite\u002FEpisodeDownload\u002FPB140D90ET6YD6\",\"fallbackResource\":null,\"fallbackResourceMimetype\":null,\"downloadCount\":0,\"status\":\"publish\",\"hasMoreContent\":false,\"chaptersUrl\":null}],\"userLikedEpisodes\":[],\"topBarIframeLoaded\":false,\"listTotalCount\":177,\"listTotalPage\":18,\"listPage\":1,\"listType\":\"all\",\"listValue\":\"\",\"listName\":\"\",\"pageLoading\":false,\"apiBaseUrl\":\"https:\u002F\u002Fjnnpbmj.podbean.com\",\"apiCommonParams\":{\"t\":\"674cc61d\",\"clientSignature\":\"e5ae0341d7eaa0a1b3a730393e322462\",\"u\":null,\"customizing\":null},\"apiCommonHeaders\":{},\"comments\":[],\"commentsTotalCount\":null,\"commentsTotalPage\":null,\"commentsPage\":null,\"commentEpisodeId\":null,\"episode\":null,\"episodeShareLink\":null,\"deepLink\":null,\"playlist\":{\"episodes\":[],\"current\":0,\"start\":0,\"stop\":0,\"playing\":true,\"playerLoading\":true,\"playbackRate\":1,\"playbackRateIndex\":1},\"toasts\":[],\"confirm\":null,\"customizeEditorFormZIndex\":999,\"lastRequestTime\":null,\"validateChangesOnBeforeunload\":true,\"windowWidth\":1000,\"VITE_FS1_CDN_URL_PREFIX\":\"https:\u002F\u002Fpbcdn1.podbean.com\u002Ffs1\",\"reloadStats\":false}}"</script> <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.0.2/js/bootstrap.bundle.min.js" integrity="sha512-72WD92hLs7T5FAXn3vkNZflWG6pglUDDpm87TeQmfSg8KnrymL2G30R7as4FmTwhgu9H7eSzDCX3mjitSecKnw==" crossorigin="anonymous" referrerpolicy="no-referrer"></script> </body> </html>